Seasonal Influenza Vaccination Resources for Health Professionals
CDC’s Advisory Committee on Immunization Practices (ACIP) voted on June 22, 2022, to preferentially recommend the use of higher dose (including high-dose and recombinant) or adjuvanted flu vaccines over standard-dose unadjuvanted flu vaccines for adults 65 years and older. The recommendation must be approved by the CDC Director before it becomes CDC policy. Updates to this page are forthcoming pending finalization of the recommendation. More information can be found online: Flu Vaccines Worked Better than Initially Estimated this Past Season & CDC’s Advisory Council Recommends Specific Flu Vaccines for Seniors
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021–22 Influenza Season
- TABLE: Influenza vaccines — United States, 2021–22 influenza season
- FIGURE: Influenza vaccine dosing algorithm for children aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2021–22 influenza seasons
- Recommendations regarding influenza vaccination of persons who report allergy to eggs
- Frequently Asked Influenza (Flu) Questions: 2021-2022 Season
- Administration of Flu Vaccines with Other Vaccines
- Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
- Pink Book: Vaccine Administration
- You Call The Shots: Vaccinating Adolescents
- Vaccine Administration Training Module
- Intramuscular (IM) Injection: Sites – YouTube
- Subcutaneous (SC or Subcut) Injection: Sites – YouTube
- Dosage & Administration (Q&A)
- Large-Scale Influenza Vaccination Clinic Planning
- Vaccine Storage and Handling Guidelines and Recommendations
- Influenza Vaccine Availability Tracking System (IVATS) , a resource to enable healthcare providers to find influenza vaccine to purchase.
- Addressing Concerns Pregnant People Might Have about Influenza Vaccine Safety
- Seasonal Influenza Vaccine Effectiveness, 2005-2020
- Flu Vaccine Effectiveness (Q&A for Health Professionals)
- Vaccine Adverse Event Reporting System (VAERS), also available by telephone at 1–800–822–7967
- Preventive Steps
- How to Prevent Flu
- Healthcare Provider Toolkit
- Frequently Asked Influenza (Flu) Questions: 2021-2022 Season
- Key Facts about Seasonal Influenza (Q&A)
- Inactivated Flu Vaccine: Vaccination Information Statement (VIS)
- Live, Intranasal Flu Vaccine: Vaccination Information Statement (VIS)
- Make a Strong Flu Vaccine Recommendation
People with egg allergies can receive any licensed, recommended age-appropriate influenza vaccine (IIV4, RIV4, or LAIV4) that is otherwise appropriate. People who have a history of severe egg allergy (those who have had any symptom other than hives after exposure to egg) should be vaccinated in a medical setting, supervised by a health care provider who is able to recognize and manage severe allergic reactions. Two completely egg-free (ovalbumin-free) flu vaccine options are available: quadrivalent recombinant vaccine and quadrivalent cell-based vaccine.